(NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NML (NML (NN Acute) (NN Kidney)) (NNP Injury) (-LRB- -LRB-) (NNP AKI) (-RRB- -RRB-)) (NN increase) (NN mortality)) (, ,) (NP (NN morbidity)) (, ,) (CC and) (NP (NML (JJ long) (HYPH -) (NN term)) (JJ adverse) (NNS events)))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ early) (NN identification)) (PP (IN of) (NP (NNP AKI)))) (VP (MD may) (VP (VP (VB improve) (NP (NP (JJ renal) (NN function) (NN recovery)) (, ,) (NP (NN decrease) (NNS comorbidities)))) (, ,) (CC and) (ADVP (RB further)) (VP (VB improve) (NP (NP (NNS patients) (POS ')) (NN survival))))) (. .))
(S (S (VP (TO To) (VP (VP (VB control) (NP (JJ certain) (NN risk) (NNS factors))) (CC and) (VP (VB develop) (NP (VBN targeted) (NN prevention) (NNS strategies)))))) (VP (VBP are) (ADJP (JJ important) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNP AKI))))))))) (. .))
(S (NP (NP (ADJP (NN Drug) (HYPH -) (NN drug)) (NNS interactions)) (CC and) (NP (NML (NN drug) (HYPH -) (NN disease)) (NNS interactions))) (VP (VBP are) (NP (NP (JJ critical) (NNS issues)) (PP (IN for) (NP (NNP AKI))))) (. .))
(S (NP (JJ Typical) (JJ statistical) (NNS approaches)) (VP (MD can) (RB not) (VP (VB handle) (NP (NP (DT the) (NN complexity)) (PP (IN of) (NP (NML (NML (NN drug) (HYPH -) (NN drug)) (CC and) (NML (NN drug) (HYPH -) (NN disease))) (NNS interactions)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN learning) (NN algorithm)) (, ,) (NP (NP (NP (JJ Deep) (NN Rule) (NNS Forests)) (-LRB- -LRB-) (NP (NN DRF)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ discovers) (NP (NP (NNS rules)) (PP (IN from) (NP (JJ multilayer) (NN tree) (NNS models)))) (PP (IN as) (NP (NP (DT the) (NNS combinations)) (PP (IN of) (NP (NP (NN drug) (NNS usages)) (CC and) (NP (NN disease) (NNS indications)))))) (S (VP (TO to) (VP (VB help) (S (VP (VB identify) (NP (JJ such) (NNS interactions))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ several) (NML (NN disease) (CC and) (NN drug)) (NNS usages)) (VP (VBP are) (VP (VBN considered) (S (VP (VBG having) (NP (JJ significant) (NN impact)) (PP (IN on) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNP AKI)))))))))))) (. .))
(S (NP (PRP$ Our) (JJ experimental) (NNS results)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NNP DRF) (NN model)) (VP (VBZ performs) (ADJP (ADJP (RB comparatively) (JJR better)) (PP (IN than) (NP (NP (UCP (ADJP (NP (JJ typical) (NN tree)) (HYPH -) (VBN based)) (CC and) (NML (NML (JJ other) (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art))))) (NNS algorithms)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN prediction) (NN accuracy)) (CC and) (NP (NN model) (NN interpretability))))))))))))) (. .))
